This site is intended for healthcare professionals
Guidelines
  • Home
  • /
  • Guidelines
  • /
  • Other endocrine disorders
  • /
  • Shared Care Guidelines: Paediatric use of Recombin...
Guideline

Shared Care Guidelines: Paediatric use of Recombinant human Growth Hormone (r-hGH, Somatropin)

Read time: 1 mins
Last updated:1st Jul 2015
Shared Care Guidelines: Paediatric use of Recombinant human Growth Hormone (r-hGH, Somatropin) - British Society for Paediatric Endocrinology and Diabetes (BSPED)


r-hGH is administered by subcutaneous injection or needle free transjection, once daily. Depending on the brand, injections may be prepared from multi-dose ampoules or by using cartridges in a multi-dose pen injection device or other disposable devices. r-hGH has a role in protein, lipid and carbohydrate metabolism, in addition to increasing linear growth in children.


Read full Guideline